Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, is seeking to change the way retinopathy of prematurity (ROP), the leading cause of childhood blindness worldwide, is treated.

Winter may be slowly giving way to spring, but the remaining cold days of the season can cause plenty of trouble for the eyes—trouble that is largely avoidable, says a Vanderbilt Eye Institute ophthalmologist.

Tonia Rex, Ph.D., assistant professor of Ophthalmology and Visual Sciences at the Vanderbilt Eye Institute, was recently named one of 10 winners of the National Institutes of Health competition for ideas on the future of vision research.

The Vanderbilt Eye Institute has solidified itself as the largest, most comprehensive ophthalmology practice in the region with the recent expansion of its Franklin practice, now called VEI Williamson County.

David Calkins, Ph.D., vice chair and director of Research for the Vanderbilt Eye Institute, was recently awarded a Research to Prevent Blindness (RPB) Senior Scientific Investigator Award.